Gainers
- Canopy Growth CGC shares gained 1.92%, closing at $35.52.
- Cronos Group CRON shares increased by 4.63% to close at $15.37.
- Akerna KERN shares rose 3.9%, to close at $13.05.
- Tilray TLRY shares gained 1.82%, closing at $42.97.
- Therapix Biosciences TRPX shares gained 47.83%, closing at $3.40, trading higher after signing a letter of intent to merge with Destiny Biosciences.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
Losers
- Aurora Cannabis ACB shares tumbled by 0.89%, closing at $6.67.
- Aphria APHA shares fell 0.0% to close at $6.17.
- CannTrust Holdings CTST shares fell 4.03% to close at $2.62.
- Curaleaf Holdings CURLF shares fell 7.27% to close at $7.40, trading lower after FDA issued an open warning letter on CBD products.
- Greenlane Holdings GNLN shares fell 1.04% to close at $7.61.
- GW Pharmaceuticals GWPH shares fell 1.03% to close at $161.43.
- HEXO HEXO shares fell 4.03% to close at $4.52.
- India Globalization Cap IGC shares tumbled by 3.76%, eventually closing at $1.28.
- Innovative Industrial IIPR shares fell 8.94% to close at $103.03.
- iAnthus Capital Holdings ITHUF shares dropped by 7.3%, to close at $2.54.
- MedMen Enterprises MMNFF shares fell 1.84% to close at $2.03.
- New Age Beverages NBEV shares fell 4.07% to close at $3.54.
- OrganiGram Holdings OGI shares tumbled by 3.19%, eventually closing at $6.07.
- Pyxus International PYX shares fell 4.86% to close at $13.69.
- cbdMD YCBD shares fell 0.75% to close at $3.97.
- Zynerba Pharmaceuticals ZYNE shares tumbled by 8.72%, eventually closing at $11.10.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
Related Stories:
Harris, Nadler Introduce Comprehensive Federal Cannabis Reform Bill
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.